Tirzepatide 50mg

Tirzepatide 50mg

Dual GIP and GLP-1 Receptor Agonist

Uncompromising Precision for Advanced Metabolic Assays

Equip your laboratory with high-purity Tirzepatide, a highly specialized, synthetic peptide engineered to act as a dual agonist for both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.

In an in-vitro environment, this complex compound allows researchers to study the synergistic effects of simultaneous dual-receptor activation. It is a critical component for prolonged cellular culture studies focusing on metabolic regulation, incretin pathways, and the modulation of beta-cell function. Available in highly concentrated 30mg and 50mg formats, this lyophilized compound ensures exact yields and sustained stability for your most demanding, high-volume laboratory assays.

🔬 Key Research Applications:

• Metabolic Pathway Analysis: Essential for in-vitro assays measuring the synergistic signaling pathways of GIP and GLP-1 receptors across isolated cellular models.

• Insulin Secretion Models: An ideal compound for empirical research observing incretin effect mechanics, beta-cell insulin secretion, and cellular energy expenditure.

• Receptor Binding Assays: Frequently utilized in tissue cultures to study competitive binding, receptor downregulation, and the structural dynamics of dual agonism.

Technical Specifications:

• Net Content: Available in 30mg and 50mg vials

• Format: Lyophilized Powder

• Storage Requirements: 2°C – 8°C (Refrigeration required to maintain structural integrity)

⚠️ Legal Disclaimer: All products supplied by Perth Peptides are strictly for in-vitro, laboratory, and scientific research purposes only. They are not intended for human consumption, veterinary use, diagnostic, or therapeutic applications. By purchasing, the researcher assumes full responsibility for safe handling and compliance with all established laboratory protocols.